This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
and an investigator in the VIVID study , which contributed to the device’s FDA approval – successfully used the Duo Venous Stent System for the first time outside of a clinical trial. Duo Hybrid has a distinct integrated design that combines multiple zones of differing mechanical properties into a single stent [3].
milla1cf Mon, 05/06/2024 - 10:55 May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative patientcare in the cardiovascular segment has announced a strategic partnership with HeartX , a pioneering MedTech company focused on research and development.
Our Interventional Cardiology Fellowship Program offers a unique opportunity for fellows to immerse themselves in high-volume centers and experience complex procedures such as angioplasties, stent placements, and Chronic Total Occlusion (CTO) interventions.
By gathering experts from different specialties, we aimed to foster collaboration and exchange ideas to improve patientcare for peripheral IVUS," said Eric A. Participants agreed that treatment standards, formal training programs and global quality metrics remain needed to improve patientcare.
Upon removal of its retrieval hook, the filter's legs are intended to expand, forming a stent-like structure that is suitable for long-term residence in the human body. For younger or thrombophilic patients, careful evaluation of the filter's suitability and extended follow-up are crucial to optimize outcomes.
Deep learning also assisted in surgical procedures by accurately predicting stent placement and postoperative complications. Furthermore, models were able to predict AA progression and patient prognosis with high accuracy.
Here is an overview of sessions, events and meetings coordinated to help members in particular specialties, sections and areas of interest learn and engage with peers and expert cardiology professionals to advance their practice, patientcare and careers. 24 Education Sessions Symposiums at ACC The “Symposiums at ACC.24”
"This study highlights the power of our cell mimic platform in driving next-generation tests that could enhance patientcare." Clinicians need better tools to guide decision making on the choice of antiplatelet therapy in coronary artery disease patients, particularly after coronary stenting.
Background:A new policy was implemented in November 2021 to reduce the length of post-anesthesia-care-unit (PACU) stay from 6 hours to 4 hours to reduce the nursing care burden and decrease the length of stay, yet how it affected patients’ events after PACU discharge needed close evaluation.
For example, interventional cardiologists can benefit from simulation labs that mimic complex cardiovascular procedures, allowing them to practice catheter insertion techniques or stent placements before applying them in a live setting.
It was stented. The possibility of anterior STEMI was not noticed during patientcare. Therefore, she underwent angiography and had a 95% LAD thrombotic culprit that, fortunately, had reperfused on its own (that's why the troponin was only 12). I noticed it much later on looking through a random stack of EKGs.
For example, interventional cardiologists can benefit from simulation labs that mimic complex cardiovascular procedures, allowing them to practice catheter insertion techniques or stent placements before applying them in a live setting.
So the RCA was stented. The patient continued to have chest pain after the RCA was reperfused, so the LAD was then stented. But by this time the patient went into cardiogenic shock and passed away. The anterior leads are more diagnostic in this case than the inferior leads. Learning points 1.
While these findings provide preliminary insight, further research is crucial to corroborate our results and delineate their potentially transformative implications on patientcare, particularly in the context of surgical interventions.
Stent placed. It would also pick up a small but important percentage of cases in which an important ECG finding potentially having a direct impact on patientcare would have been missed had I not been overreading ECGs. : Now it is not subtle: there is clear, obvious inferior posterior OMI. Pre- procedure TIMI 0 flow was noted.
By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable. These costs represent a massive portion of total health expenditures.
The documentary includes interviews with pioneers of interventional cardiac catheterization, in which multiple x-rays are used to navigate stents, valves, pacemakers and other devices through the vascular system and into and around the heart to restore patient health without resorting to the risks posed by open-heart surgery.
Staying informed about these cutting-edge developments is critical for providing exceptional patientcare. Join us as we examine the landmark approvals that are revolutionizing patient outcomes. The first half of 2024 has ushered in a wave of transformative FDA approvals in cardiorenal metabolic health.
August 2024 Approvals Minima Stent System (P240003) (Approval Date: August 28, 2024) The Minima Stent System is an expandable cobalt-chromium metal mesh tube to reopen blood vessels in neonates, infants, and children with Coarctation of the Aorta and Pulmonary Artery Stenosis, specifically designed to expand as younger patients grow.
Patient has 4.5/10 Case Continued This EKG was interpreted as normal by the clinicians overseeing this patient'scare. The patient was given nitroglycerin, but his blood pressure dropped to 70 systolic, he became dizzy, and he still had chest pain. The thrombus was aspirated and the distal RCA was stented.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content